[Study of anti-lithogenic action of zinc sulfate in experimental lithiasis in the rat].
Sodium oxalate injected into young rats, via the intraperitoneal route, at a dose of 8 mg per 100 g of body weight, induced death in 50 p. cent of animals, and induced calcium oxalate crystals in renal tissue. When a zinc solution was administered prior to sodium oxalate, at the dose of 12 micrograms/100 g of body weight, the mortality rate decreased, and at the same time oxalate and calcium deposits were significant reduced (respectively P less than 0.01; P less than 0.01). The same results were found when zinc was administered at 24 micrograms/100 g of body weight, however, oxalic accumulation was found to be significantly lower in this group than in the group treated at 12 micrograms. This protection against calcium oxalate deposits was complete in the animals treated with various doses of zinc, because compared to reference animals, which received distilled water, calcium accumulation in these groups was not different and oxalate accumulation was also found to be lower (respectively P less than 0.05; P less than 0.001). Microscopic examination showed calcium crystals only in the group treated with sodium oxalate, localized preferentially in the renal papilla. All these experiments conclude on the total inhibitory effect of zinc on experimental lithiasis induced by oxalic acid, even though it was administered at a dose of only 12 micrograms/100 g of body weight.
Sakly
R
R
Service de Nutrition Expérimentale, Institut National de Nutrition, Tunis, Tunisie.
Zarrouk
K
K
Hedhili
A
A
Achour
A
A
Mbazzaa
A
A
D000818:Animals; D002118:Calcium / Q000737:chemistry; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D007669:Kidney Calculi / Q000737:chemistry / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D010070:Oxalates / Q000737:chemistry; D051381:Rats; D011919:Rats, Inbred Strains; D013431:Sulfates / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D015032:Zinc / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D019287:Zinc Sulfate
D010070:Oxalates; D013431:Sulfates; D019287:Zinc Sulfate; D015032:Zinc; D002118:Calcium
Etude sur l'action anti-lithogène de sulfate de zinc vis-à-vis de la lithiase expérimentale chez le rat.